Duke Cancer Institute

Duke Cancer Institute is a comprehensive cancer center located at Duke University in Durham, North Carolina, and is affiliated with the Duke University Health System and the Duke University School of Medicine. The institute is a member of the National Comprehensive Cancer Network and is accredited by the American College of Surgeons Commission on Cancer. It has been recognized for its excellence in cancer care by U.S. News & World Report and is a major referral center for patients from across the United States and around the world, including Europe, Asia, and Latin America.

● Overview

The institute is led by Michael B. Kastan, and its faculty includes prominent cancer researchers and clinicians such as Joseph R. Nevins, H. Kim Lyerly, and Daniel S. Grosu. The institute is organized into several disease-specific programs, including the Brain Tumor Center, the Breast Cancer Program, and the Lung Cancer Program, and offers a range of services including radiation oncology, medical oncology, and surgical oncology. Patients at the institute have access to clinical trials sponsored by the National Cancer Institute and other organizations, including the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. The institute is also a member of the National Cancer Institute-sponsored Alliance for Clinical Trials in Oncology and the American Association for Cancer Research.

● History

The institute was established in 1972 as the Duke Comprehensive Cancer Center, and has since grown to become one of the largest and most respected cancer centers in the United States. The institute has a long history of innovation in cancer research and treatment, and has been at the forefront of developments in immunotherapy, gene therapy, and stem cell transplantation. The institute has also been a leader in the development of cancer genomics and precision medicine, and has collaborated with other leading cancer centers, including the Memorial Sloan Kettering Cancer Center, the University of Texas MD Anderson Cancer Center, and the Stanford Cancer Institute. The institute has received funding from the National Institutes of Health, the American Cancer Society, and the Susan G. Komen for the Cure.

● Research_and_Clinical_Trials

The institute is home to a wide range of research programs, including the Duke Cancer Institute Center for Cancer Genomics, the Duke Cancer Institute Center for Immunotherapy, and the Duke Cancer Institute Center for Stem Cell and Regenerative Medicine. The institute's researchers have made significant contributions to the understanding of cancer biology and the development of new cancer treatments, and have collaborated with other leading researchers at institutions such as Harvard University, Stanford University, and the University of California, San Francisco. The institute is also a major center for clinical trials, and has participated in trials sponsored by the National Cancer Institute, the Food and Drug Administration, and the Pharmaceutical Research and Manufacturers of America. The institute has also collaborated with industry partners, including Pfizer, Merck & Co., and Genentech.

● Clinical_Care

The institute provides comprehensive clinical care to patients with all types of cancer, including breast cancer, lung cancer, colon cancer, and leukemia. The institute's clinicians are experts in the latest cancer treatments, including surgery, chemotherapy, radiation therapy, and immunotherapy. Patients at the institute have access to a range of supportive care services, including pain management, nutrition counseling, and psychological support. The institute is also a leader in the development of personalized medicine and precision medicine, and has collaborated with other leading cancer centers, including the University of Chicago, the University of Pennsylvania, and the Johns Hopkins University. The institute has also partnered with community hospitals, including the Duke Regional Hospital and the Duke Raleigh Hospital.

● Education_and_Training

The institute offers a range of educational and training programs for students, residents, and fellows, including the Duke University School of Medicine MD program, the Duke Cancer Institute Fellowship Program, and the Duke University Graduate School PhD program. The institute's faculty includes prominent educators and mentors, such as James R. Allison, Elizabeth Blackburn, and David Baltimore. The institute has also collaborated with other leading educational institutions, including the Massachusetts Institute of Technology, the California Institute of Technology, and the University of Cambridge. The institute has received funding from the National Institutes of Health to support its educational and training programs.

● Community_Outreach_and_Partnerships

The institute is committed to community outreach and partnerships, and has collaborated with a range of organizations, including the American Cancer Society, the Susan G. Komen for the Cure, and the Leukemia & Lymphoma Society. The institute has also partnered with community hospitals and health systems, including the Duke LifePoint Healthcare and the Carolinas HealthCare System. The institute has received funding from the Centers for Disease Control and Prevention to support its community outreach and partnerships. The institute has also collaborated with international organizations, including the World Health Organization and the International Union Against Cancer. The institute is a member of the Association of American Cancer Institutes and the National Cancer Institute-sponsored Cancer Centers Program. Category:Cancer research